|
Dinner Meeting
|
|
Attendants comments:
|
|
With the current focus on prevention of Central Line Associated Bloodstream Infection there are increasing issues of accountability when infections do occur. Groups such as The Centers for Disease Control, Institute for Healthcare Improvement, Society of Healthcare Epidemiology of America and Joint Commission have all contributed to the growing list of infection prevention measures necessary for acute care hospitals. The Centres for Medicare and Medicaid (CMS) ruled in 2008 that infections associated with central venous catheters inserted during a patient stay in acute care were preventable. The legal implications of the CMS ruling are far reaching in that when infection does occur it is due to a mistake by the healthcare providers. The liability now associated with failure to apply preventative practices and ensure compliance by staff with those practices is rapidly growing with new cases surfacing each month. How can you protect your practice and that of your hospital? Ensuring application of best practices is challenging, but not impossible. Careful consideration of the guidelines and technologies available will provide some direction as do published hospital success initiatives. Actual cases are provided for this presentation dealing with injuries and death related to infection with Central Venous Catheters and peripheral venous catheters.
|
|
The NEO-AVA Board would like to extend our deepest gratitude to
3 M Angiodynamics Arrow International, Teleflex Bard Access Systems, Statlock Becton, Dickinson and Company (BD) Johnson & Johnson BIOPATCH Carefusion Centurion Medical Products Clinical Technology Inc. Cook Medical Excelsior Medical Genentech USA Hospira, Inc. ICU Medical MedComp Medical Action Industries Navilyst Medical PDI (Professional Disposables International) Rymed Technologies Smiths-Medical Corporation SonoSite, Inc.
|